<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Combination &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/combination/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 17 Oct 2026 07:38:21 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Combination &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Approval lag and loss for biologic-device combination products in Japan and the United States</title>
		<link>https://bioengineer.org/approval-lag-and-loss-for-biologic-device-combination-products-in-japan-and-the-united-states/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Sat, 17 Oct 2026 07:38:21 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Approval]]></category>
		<category><![CDATA[biologic-device]]></category>
		<category><![CDATA[Combination]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[loss]]></category>
		<category><![CDATA[products]]></category>
		<category><![CDATA[scientific research]]></category>
		<category><![CDATA[States]]></category>
		<category><![CDATA[United]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=425093</guid>

					<description><![CDATA[For millions of patients who inject biologic medicines at home, the device attached to the vial is as consequential as the molecule inside it. Prefilled syringes, autoinjectors, multidose pen injectors, on-body injectors, and cartridge-based systems have transformed chronic disease management,]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">425093</post-id>	</item>
		<item>
		<title>Why the Immune System Fails Some Bladder Cancers and How Scientists Are Fighting Back</title>
		<link>https://bioengineer.org/why-the-immune-system-fails-some-bladder-cancers-and-how-scientists-are-fighting-back/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Sat, 17 Oct 2026 06:23:22 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[BCG immunotherapy]]></category>
		<category><![CDATA[bladder cancer]]></category>
		<category><![CDATA[Cancer Immunology]]></category>
		<category><![CDATA[Clinical Research]]></category>
		<category><![CDATA[Combination]]></category>
		<category><![CDATA[combination therapy]]></category>
		<category><![CDATA[Immune checkpoint inhibitors]]></category>
		<category><![CDATA[immune evasion]]></category>
		<category><![CDATA[Immunotherapy resistance]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[therapy]]></category>
		<category><![CDATA[tumor microenvironment]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=424919</guid>

					<description><![CDATA[A new review explains why BCG immunotherapy fails in some bladder cancer patients and outlines emerging combination strategies designed to overcome immune evasion and improve survival outcomes.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">424919</post-id>	</item>
	</channel>
</rss>
